期刊文献+

5-溴烟腈的合成及表征 被引量:4

Synthesis and Characteristics of 5-Bromo-nicotinonitrile
下载PDF
导出
摘要 以5-溴烟酸(Ⅰ)为起始原料,经SOCl2氯化制备5-溴烟酰氯(Ⅱ),收率为90%;Ⅱ与氨水在冰水浴(0~10℃)下反应合成了5-溴-烟酰胺(Ⅲ),收率为79%;以三氯氧磷为氧化剂,在110%回流反应,将Ⅲ氧化制备成目标产物5-溴烟腈(Ⅳ),收率为68%。以此方法制备5-溴烟腈(Ⅳ)总收率可达到48%。中间产物和目标产物通过傅里叶变换红外光谱和核磁共振氢谱进行了结构确证。 Firstly, 5-Bromo-nicotinic acid, the initial reactant, was chlorinated with SOC12, thus preparing 5 -Bromo-nicofinatc with 90% yield; secondly, 5-Bromo-nicotinamide was prepared from the reaction of 5-Bromo -nieotinate with ammonium aqueous at 0 - 10 ℃ with 79% yield; thirdly, with POC13 as the oxidant, 5-Bromo- nicotinonitrile was obtained by 5-Bromo-nicotinamide via a reflux reaction at 110 ℃ with 68% yield. The total yield was more than 48% by this method. The structures of intermediates and target product were characterized with FT-IR and ^1HNMR.
出处 《辽东学院学报(自然科学版)》 CAS 2010年第1期5-7,共3页 Journal of Eastern Liaoning University:Natural Science Edition
关键词 5-溴烟腈 5-溴烟酸 5-溴烟酰胺 合成 5-Bromo-nicotinonitrile 5-Bromo-nicotinic acid 5-Bromo-nicotinamide synthesis
  • 相关文献

参考文献9

  • 1CHEN C,WILCONXEN K M,HUANG C Q.et al.Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylamino-pyrazolo[1,5-α] pyrimidine (NBI 30775/R121919) and structure-activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists[J].Journal of Medicinal Chemistry,2004,47 (19):4787-4798. 被引量:1
  • 2BECHRMAN E J.The bacterial oxidation of nicotinic acid[J].Archives of Microbiology,1976,110(1):87-90. 被引量:1
  • 3BEHRMAN E J,STANIER R Y.Observations on the oxidation of halogenated nicotinic acids[J].Journal of Medicinal Chemistry,1957,228:947-953. 被引量:1
  • 4HUGHES D E.The inhibition of growth and cozymase synthesis in bacteria by halogen-substituted nicotinic acids[J].Biochemical Journal,1954,57(3):485-495. 被引量:1
  • 5WOOLF N,STEEN E,ROSEN D,et al.The effect of anti-lipolytic agents on isoprenaline-induced myocardial necrosis in the rat.British Journal of Experimental Pathology,1977,58(4):438-443. 被引量:1
  • 6HAYAKAWA M,KAIZAWA H,MORITOMO H.Preparation of condensed heteroaryl derivatives as phosphatidylinositol 3-kinase inhibitors and anticancer agents[P].Japan,WO 018346,2001,11,8. 被引量:1
  • 7OKUMURA Y,MURATA Y,MANO T.Benzimidazole cyclooxygneaes-2-inhibitors[P].US 6310079,2001,10,25. 被引量:1
  • 8ROSNNAE B,DANIAL C J,MIEHAEL G J.Preparation of N-(isoxazoloquinolinycyclohexyl)-carboxamides and analogs as MRP1 inhibitors[P].WO 0146199,2001,6,28. 被引量:1
  • 9BROWN D.G,BARE T M,MURPHY M.Preparation of 1,2,5,10-tetrahydropydidazino[4,5-b] quinoline-1,10-diones for the treatment of pain[P].WO 0147524,2001,7,5. 被引量:1

同被引文献64

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部